AU2001255320A1 - Secreted proteins - Google Patents

Secreted proteins

Info

Publication number
AU2001255320A1
AU2001255320A1 AU2001255320A AU5532001A AU2001255320A1 AU 2001255320 A1 AU2001255320 A1 AU 2001255320A1 AU 2001255320 A AU2001255320 A AU 2001255320A AU 5532001 A AU5532001 A AU 5532001A AU 2001255320 A1 AU2001255320 A1 AU 2001255320A1
Authority
AU
Australia
Prior art keywords
secreted proteins
secreted
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255320A
Inventor
Janice Au-Young
Yalda Azimzai
Sajeev Batra
Mariah R. Baughn
Christopher M. Bruns
Angelo M Delegeane
Jennifer A. Griffin
April Hafalia
Jennifer L. Hillman
Preeti Lal
Dyung Aina M. Lu
Danniel B. Nguyen
Chandra Patterson
Jennifer L. Policky
Roopa Reddy
Y. Tom Tang
Catherine M. Tribouley
Monique G. Yao
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Publication of AU2001255320A1 publication Critical patent/AU2001255320A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001255320A 2000-04-14 2001-04-11 Secreted proteins Abandoned AU2001255320A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US19785400P 2000-04-14 2000-04-14
US60/197,854 2000-04-14
US20237300P 2000-05-04 2000-05-04
US60/202,373 2000-05-04
US20589900P 2000-05-18 2000-05-18
US60/205,899 2000-05-18
US21015500P 2000-06-01 2000-06-01
US20940100P 2000-06-01 2000-06-01
US60/210,155 2000-06-01
US60/209,401 2000-06-01
PCT/US2001/011861 WO2001079291A2 (en) 2000-04-14 2001-04-11 Secreted proteins

Publications (1)

Publication Number Publication Date
AU2001255320A1 true AU2001255320A1 (en) 2001-10-30

Family

ID=27539378

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255320A Abandoned AU2001255320A1 (en) 2000-04-14 2001-04-11 Secreted proteins

Country Status (6)

Country Link
US (2) US20030215822A1 (en)
EP (1) EP1328630A2 (en)
JP (1) JP2004518402A (en)
AU (1) AU2001255320A1 (en)
CA (1) CA2405781A1 (en)
WO (1) WO2001079291A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1472701A (en) * 1999-11-12 2001-06-06 Human Genome Sciences, Inc. 28 human secreted proteins
WO2001092495A2 (en) * 2000-05-26 2001-12-06 Millennium Pharmaceuticals, Inc. A human lysyl ixodase (47765) and uses thereof
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
EP1445614A1 (en) * 2003-02-06 2004-08-11 Institut National De La Sante Et De La Recherche Medicale (Inserm) A method for the in vitro assessment of the progression status of an HIV virus in an invidual
CA2621070A1 (en) 2005-09-02 2007-03-08 Toray Industries, Inc. Composition and method for diagnosing kidney cancer and estimating kidney cancer patient's prognosis
SI2185198T1 (en) 2007-08-02 2015-04-30 Gilead Biologics, Inc. Lox and l0xl2 inhibitors and uses thereof
AU2009246928A1 (en) * 2008-02-21 2009-11-19 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Biologically active recombinant human Saposin C and PSAP
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG2014004816A (en) * 2009-08-21 2014-03-28 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
BR112012008080A2 (en) * 2009-08-21 2017-07-04 Gilead Biologics Inc in vivo screening assays.
CA2789022A1 (en) * 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
CN116449030B (en) * 2023-06-12 2023-08-15 天津德祥生物技术股份有限公司 Method for cross-matching platelets

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6140056A (en) * 1999-01-27 2000-10-31 Millennium Pharmaceuticals, Inc. MSP-18 protein and nucleic acid molecules and uses therefor
EP1098970A1 (en) * 1998-07-23 2001-05-16 Smithkline Beecham Plc Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors

Also Published As

Publication number Publication date
WO2001079291A2 (en) 2001-10-25
US20030215822A1 (en) 2003-11-20
WO2001079291A3 (en) 2003-05-01
CA2405781A1 (en) 2001-10-25
EP1328630A2 (en) 2003-07-23
US20050079538A1 (en) 2005-04-14
JP2004518402A (en) 2004-06-24

Similar Documents

Publication Publication Date Title
AU2001271683A1 (en) Novel secreted proteins
AU2001280471A1 (en) Novel secreted proteins and their uses
AU2002233994A1 (en) Secreted proteins
AU2002361452A1 (en) Secreted proteins
AU2001270045A1 (en) Secreted proteins
AU2002353227A1 (en) Secreted proteins
AU2001227833A1 (en) 71 human secreted proteins
AU2002232596A1 (en) Secreted human proteins
AU2002342010A1 (en) Secreted proteins
AU2001255320A1 (en) Secreted proteins
AU2001237957A1 (en) 17 human secreted proteins
AU2002354803A1 (en) Secreted proteins
AU2002211220A1 (en) Secreted proteins and their uses
AU2002252700A1 (en) Secreted proteins
AU2002255733A1 (en) Secreted proteins
AU2001294719A1 (en) Secreted human proteins
AU2001290551A1 (en) Secreted proteins and their uses
AU2001229366A1 (en) Secreted proteins
AU2002236440A1 (en) Novel secreted proteins and their uses
AU2002258657A1 (en) Secreted proteins
AU2002327533A1 (en) Secreted proteins
AU2002239747A1 (en) Cystoskeleton-associated proteins
AU2001244863A1 (en) Apoptin-associating protein
AU2001229507A1 (en) 21 human secreted proteins
AU2390800A (en) Secreted proteins